<code id='3BA5108710'></code><style id='3BA5108710'></style>
    • <acronym id='3BA5108710'></acronym>
      <center id='3BA5108710'><center id='3BA5108710'><tfoot id='3BA5108710'></tfoot></center><abbr id='3BA5108710'><dir id='3BA5108710'><tfoot id='3BA5108710'></tfoot><noframes id='3BA5108710'>

    • <optgroup id='3BA5108710'><strike id='3BA5108710'><sup id='3BA5108710'></sup></strike><code id='3BA5108710'></code></optgroup>
        1. <b id='3BA5108710'><label id='3BA5108710'><select id='3BA5108710'><dt id='3BA5108710'><span id='3BA5108710'></span></dt></select></label></b><u id='3BA5108710'></u>
          <i id='3BA5108710'><strike id='3BA5108710'><tt id='3BA5108710'><pre id='3BA5108710'></pre></tt></strike></i>

          leisure time

          leisure time

          author:focus    Page View:2634
          dose of methadone
          A dose of methadone Kevin D. Liles/AP

          The federal government is reforming methadone care for the first time in over two decades. But how far do the changes actually go?

          To many methadone clinics, the Biden administration’s recent refresh of the rules governing opioid treatment programs represents an unprecedented opportunity to offer care that is more compassionate and responsive to patients’ needs. To many patient advocates, however, it simply nibbles around the edges. 

          advertisement

          The reality is likely somewhere in between: It will depend, in large part, on whether state-level regulators embrace the changes, and whether individual clinics actually implement them. In reform-oriented states, and at patient-centered clinics, the new rules could make a world of difference for people seeking addiction treatment. 

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more
          Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline
          Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline

          Bayer'sU.S.president,SebastianGuth,emphasizedataninterviewattheSTATofficesinBostonthatthepharmacompa

          read more
          Peter Hotez and the public health issue of online harassment
          Peter Hotez and the public health issue of online harassment

          AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

          read more

          DOJ reversal could clear way for Carroll's 1st lawsuit against Trump to proceed

          2:07E.JeanCarrollwalksoutofManhattanfederalcourt,May9,2023,inNewYork.JohnMinchillo/AP,FILETheJustice